Latest filing published 15 Dec 2006 for KOS PHARMACEUTICALS INC, €413k.
No signal scores available.
Filings by Mark M. D. Novitch span 2 companies, the busiest being KOS Pharmaceuticals Inc and Guidant Corp. In total, 8 filings cover trades dated from 10 August 2005 to 13 December 2006.
No open-market purchase appears, only 2 sales worth €580k. Outside the open market, there are 1 share grant and 2 option exercises. Since January 2006: no purchases and 2 sales on the market.
The newest entry dates from 15 December 2006: a transaction of €413k, in KOS Pharmaceuticals Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations